COMPANY
AbbVie Deutschland GmbH & Co. KG
AbbVie Deutschland GmbH & Co. KG: marketing authorisation holder, trial sponsor for Linaclotide, Carfilzomib, as stated by public registers.
Also written as: Abbvie Deutschland GmbH & Co. KG.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Linaclotide | Constella (EMEA/H/C/002490), Authorised Regulator EMA |
|---|
TRIAL SPONSOR
Sponsors registered clinical trials of the peptide.
| Carfilzomib | 3 registered trials Trial register EU CTIS |
|---|---|
| Linaclotide | 2 registered trials Trial register EU CTIS |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.